183 results
Page 2 of 10
20-F/A
EX-12.1
gzpkg90
9 Sep 22
Annual report (foreign) (amended)
4:15pm
6-K
EX-99
ut9ow 9vr0
16 Aug 22
BioLineRx Reports Second Quarter 2022 Financial Results
7:19am
6-K
EX-99
nds7f
16 Jun 22
BioLineRx Announces Appointment of Commercial Strategy
7:05am
6-K
EX-99
qn1b7 ewaemr
27 May 22
2022 Annual General Meeting of Shareholders
4:30pm
6-K
EX-99
dd8nvsle0luu
27 Oct 21
2021 Annual General Meeting of Shareholders
5:05pm
6-K
EX-10.1
7mwabqz
3 Sep 21
Current report (foreign)
4:30pm
424B5
w6e6 1x4mtik
3 Sep 21
Prospectus supplement for primary offering
4:29pm
POS AM
rf4eyde41pr
23 Feb 21
Prospectus update (post-effective amendment)
9:12am
6-K
EX-99
vhdmt0ndv 1l
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
424B5
kw5wnon8zpcovv20ibq
21 Jan 21
Prospectus supplement for primary offering
4:31pm
424B5
qvh7kho6 zc
19 Jan 21
Prospectus supplement for primary offering
5:00pm